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Abstract
Research into the mechanism of RNA interference has seen immense progress over the past few
years. Recent studies of the protein Dicer, a key enzyme in the process, have started to reveal
how this single enzyme is targeted to different RNA-silencing pathways.
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The nuclease Dicer was identified as the protein responsible
for cutting double-stranded RNA (dsRNA) into small interfer-
ing RNAs (siRNAs) of approximately 21 bp during the process
of RNA interference (RNAi) [1]. These siRNAs were first iden-
tified in RNAi-like silencing processes in plants [2], and were
later also found associated with RNAi in animals [3,4]. siRNAs
are incorporated into ribonuclease complexes called RNA-
induced silencing complexes (RISCs), where their role is to
confer specificity for the cleavage of a homologous mRNA.
Within a RISC, the siRNA is bound by RDE-1, a protein of the
Argonaute family [5], which initiates the destruction of the
targeted mRNA by introducing a single-strand nick in the
mRNA in the region base-paired to the siRNA [6,7]. Even
early on, however, it became clear that Dicer produces other
kinds of small RNAs apart from siRNAs and that these were
bound by similar, but different, complexes, resulting in multi-
ple parallel silencing pathways mediated by a variety of small
RNAs [8]. Some of these pathways, such as those involving
siRNAs, lead to mRNA degradation, some to translation inhi-
bition (those involving microRNAs, or miRNAs) [9], and yet
others to the remodeling of chromatin structure [10]. Despite
the existence of so many different small RNA pathways,
animal genomes encode only one Dicer enzyme. So how is this
enzyme targeted in a regulated fashion to these various path-
ways? A study published in Cell earlier this year by Duchaine
et al. [11] starts to shed light on this problem by showing the
physical interaction of Dicer with a variety of proteins involved
in these pathways.
Finding the partners 
Reasoning that proteins involved in guiding Dicer to the dif-
ferent pathways should physically interact with the Dicer
protein, the team led by Craig Mello [11] used a proteomics
approach to identify proteins that co-purify in immuno-
precipitation (IP) procedures. Using antibodies directed
against the Dicer protein from Caenorhabditis elegans,
protein complexes were pulled out of extracts, and analyzed
in bulk using a multidimensional protein identification tech-
nology (MudPIT) approach [12]. This mass-spectrometry-
based technology is capable of recognizing and identifying
relatively small amounts of a protein in complex mixtures
and is a powerful way of identifying  proteins in a given
sample. Repeating this procedure several times and compar-
ing samples from animals with or without Dicer protein led to
the robust identification of 20 proteins that interact with
Dicer. Another 88 proteins were identified in a less repro-
ducible way - that is, they were identified as Dicer interactors
in only one of the purifications - and were not studied further.
Nevertheless, given the fact that a well-known Dicer interac-
tor, RDE-1 [13,14], barely made it to the top-20 list, many rel-
evant interactors may well be represented in this ‘lower
confidence’ list. Confining themselves to the ‘high-confi-
dence’ list of 20, Duchaine et al. [11] used reverse genetics to
elucidate the roles of these proteins by identifying deletion
alleles of the genes and studying their role in Dicer-related
pathways.
On the basis of the predicted functions of the 20 candidate
proteins, Duchaine et al. [11] could divide them into five
groups. Two groups could have been expected from previous
work: these are known proteins involved in the siRNA
pathway, which the authors call the ‘RNAi group’, and
known proteins involved in the miRNA pathway - the
‘miRNA group’. These two groups can be regarded as a posi-
tive control for the approach, as most of them have beenassociated with Dicer in previous studies, and they will not
be discussed here. A third group is composed of six proteins
with unknown functions. This group was not studied further
by Duchiane et al. [11] - not because these proteins would be
uninteresting, but because the phenotypes associated with
the available deletion alleles are very pleiotropic, and it will
take significant extra effort to reach meaningful conclusions
on their precise roles in RNAi-related pathways. The most
interesting findings of Duchaine et al. [11] come from the
remaining two groups of proteins.
Two new partners for Dicer 
One of these groups (the so-called ‘PIR-1 group’) contains two
evolutionarily conserved proteins - DRH-3 and PIR-1 - that
are both required for RNAi and for viability [11]. C. elegans
PIR-1 is the ortholog of the human PIR1 protein [15], which is
an RNA phosphatase that removes the γ- and β-phosphate
groups from the 5 ends of RNA molecules [16]. C. elegans
mutants that lack PIR-1 develop normally but arrest at the last
larval stage and hence never produce progeny. At a molecular
level, these animals are resistant to RNAi, and this is because
they do not produce any siRNAs from dsRNA [11]. 
These mutants do, however, accumulate a larger RNA
species when attempts are made to trigger RNAi experimen-
tally. This RNA is most probably the product of one of the
RNA-dependent RNA polymerases (RdRPs) that have been
shown to be essential for RNAi in C. elegans [17,18]. These
polymerases are involved in the production of the so-called
‘secondary’ siRNAs that lie 5 of the region recognized by the
dsRNA [18]. They turn the initial single-stranded mRNA
target into dsRNA, which is then thought to be cleaved by
Dicer to produce these new siRNAs. RdRPs can start de novo
RNA synthesis on an RNA template [19], which leads to
dsRNA molecules that have a triphosphate group on the 5
end of one strand (the newly synthesized strand), and a
methylated cap on the 5 end of the other strand (the origi-
nal mRNA molecule). These are presumably bad substrates
for Dicer, as 5-monophosphate groups are preferred
throughout the RNAi pathway [20]. PIR-1 would therefore
seem to be the perfect candidate to convert these dsRNA
molecules into better Dicer substrates, enabling siRNA pro-
duction (Figure 1). This model makes the following two pre-
dictions: first, sequences downstream of the original target
should not be present in the accumulating RNA intermedi-
ates; and second, primary siRNAs (the siRNAs that are
produced directly from exogenously added dsRNA) should
be formed in pir-1 mutants, as long as one uses dsRNA
with 5-monophosphate ends.
Some discrepancies remain, however. If the only role of PIR-1
is to convert RdRP products into suitable Dicer substrates,
then why do no RdRP mutants show pir-1-like phenotypes
[17,18]? Most probably, PIR-1 is performing additional tasks,
perhaps in other small-RNA-mediated silencing pathways or
even in unrelated pathways. The fact that PIR1 is also found
in human cells could suggest that this protein is indeed
doing more than just helping RdRPs, as no involvement of
RdRPs in human RNAi has been observed. On the other
hand, PIR1 may help in fighting virus infections in human
cells: RNA viruses have their own RdRPs, and if human cells
are to take the dsRNA intermediates of these viruses through
the RNAi pathway, they have to turn them into suitable
Dicer substrates, just as C. elegans needs to process its
RdRP products to trigger RNAi. This scenario would predict
that PIR1-deficient human cells would be more sensitive to
RNA virus infections.
The second protein in the ‘PIR-1 group’ [11] is the RNA heli-
case DRH-3. This enzyme appears to be required for RNAi
only in the germline, and drh-3  mutants  display severe
germline defects and defects in the first embryonic cell divi-
sion. DRH-3 is a member of a conserved protein family,
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Figure 1
RNA-dependent RNA polymerases (RdRPs) synthesize RNA on RNA
templates. During RNAi in C. elegans this process is used to amplify the
initial RNAi response, and without it, no effect of RNAi is observed. The
precise RNA molecules that serve as templates for RdRPs have not been
identified, but it is assumed that they will at least contain the 5’ end of the
mRNA that is targeted by RNAi, and hence will have a 5’-cap structure.
De novo RNA synthesis on this RNA template would result in a 5’ end
having a triphosphate group (indicated with three stars). PIR-1 may
function in trimming such ends to monophosphate groups, allowing Dicer
to cleave the dsRNA. The RNA species accumulating when PIR-1 is
absent is indicated in green.
RdRP
5′ cap 3′OH
Single-stranded RNA
5′ triphosphate
5′ monophosphate
PIR-1
Dicer (starting at the 
5′ monophosphate end)
siRNAsmembers of which are also found in human cells [21]. drh-3
mutant embryos show defects in chromosome segregation
and in the production of endogenous siRNAs (see below),
suggesting the involvement of a small-RNA-mediated
pathway in the establishment of proper chromosome
dynamics. The latter function has been clearly demonstrated
in the fission yeast Schizosaccharomyces pombe [10], but in
animals it has still to be unambiguously established. Inter-
estingly, other C. elegans RNAi mutants also show hints of
chromosome-segregation defects [13,22]. Many of these
mutants display a so-called Him (high incidence of males)
phenotype, which is indicative of X-chromosome mis-
segregation. Whether any of these other genes work together
with  DRH-3 is unknown.
In drh-3 homozygous mutant animals, decreased cell prolif-
eration in the germline is observed; that is, the mitotic phase
of germ-cell production is affected [11]. This defect might be
related to previously described germline under-proliferation
in worms with compromised activity of the Piwi protein, a
member of the Argonaute family [23]. It may be that DRH-3
and Piwi function in the germline in the same way that the
known Dicer interactors DRH-1, DRH-2 and RDE-1 function
in the soma [14]. 
Competition between small RNA pathways 
The second group of novel players identified by Duchaine et
al. [11] as interacting with Dicer is called the ‘enhanced
RNAi (Eri) group’ and may constitute a multiprotein
complex involved in the endogenous RNAi that is initiated
naturally in C. elegans against certain genes at certain times.
Small RNAs that are associated with these endogenous RNAi
responses are named endo-siRNAs when they match a
known C. elegans gene or tiny noncoding RNAs (tncRNAs)
when they do not [24]. Duchaine et al. [11] show that the
Dicer-interacting proteins that fall into this group have
effects on the production of these small RNA molecules (see
also [25]), as does DRH-3, as described above. DRH-3 also
physically interacts with the proteins of this group. Interest-
ingly, not all mutants in this group affect all types of small
RNAs to the same extent, indicating that we are only just
beginning to see how these small RNA molecules are pro-
duced and how they function. 
Duchaine  et al. [11] also show that the endogenous RNAi
pathway competes with the experimental, or exogenous, RNAi
pathway: triggering exogenous RNAi decreases the effect of
the endogenous RNAi pathway. Conversely, genetic disruption
of the endo-siRNA pathway makes the exo-siRNA pathway
more efficient. These pathways probably share a number of
components - they share Dicer at least - and so when one
pathway is compromised, the other becomes more effective.
These results indicate that all these pathways are in delicate
balance, and that unexpected side-effects might be observed in
RNAi experiments as a result of disturbing this balance.
It is interesting that both exo- and endo-RNAi pathways
appear to use similar proteins. Both use Dicer, obviously, but
Duchaine et al. and other workers find that both pathways
also need an RdRP [11,17,18,25], RNA helicases [11,14,26]
and (at least to some extent) 3-5 exonucleases [11,22,25].
The Argonaute protein of the endo-siRNA pathway has yet to
be identified. There are apparently many flavors of RNAi
machines, all using their own specialized set of proteins.
This may be part of the answer to the question raised above:
why does the pir-1 mutant have such a severe phenotype?
Maybe PIR-1, like the other essential RNAi factor DRH-3, is
also required for the production of endo-siRNAs and
tncRNAs. Future experiments will tell.
A picture emerges in which Dicer is targeted to many differ-
ent pathways through interactions with different proteins.
To produce the required allocation of Dicer in a given situa-
tion, proteins from different pathways compete for it. This
may mean that Dicer is the rate-limiting step in many small-
RNA-mediated processes. Downstream of Dicer, many vari-
ants of the RNAi pathway operate, each of them guiding
their effector molecules to specific sequences, either in RNA
or in chromosomal DNA. 
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